protein kinase c without lipid activator C, an elusive therapeutic target? Protein kinase C peptide modulators.

Scientific studies appear to support this

In addition, the ratio of neuroprotective to neurotoxic kynurenine metabolites differs between healthy controls and ME/CFS patients [46], accompanied and probably often preceded by a general decrease in tryptophan [25, 74]

This makes ALC and CoQ10 a naturally complementary pair: ALC delivers the substrate, CoQ10 drives the conversion.* We use the HCl form specifically for its stability and bioavailability

Glycemic improvements in patients with type 2 diabetes occur relatively quickly, with fasting glucose reductions often observable within the first week and hemoglobin A1c improvements becoming apparent over 812 weeks

Exposed cancer patients may suffer difficulty in processing information, inability to perform multi-tasks, difficulties in memory, learning, and attention (Koppelmans et al